An investigation for investors in Amedisys Inc (NASDAQ:AMED) shares over potential securities laws violations by Amedisys Inc was announced and NASDAQ:AMED stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 06/10/2015 -- An investigation on behalf of investors of Amedisys Inc (NASDAQ:AMED) shares over potential securities laws violations by Amedisys Inc and certain of its directors and officers in connection certain financial statements was announced.
Investors who purchased shares of Amedisys Inc (NASDAQ:AMED), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Amedisys Inc (NASDAQ:AMED) concerning whether a series of statements by Amedisys Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On May 28, 2015 Amedisys Inc announced that, on May 21, 2015, it received a Subpoena Duces Tecum ("Subpoena") issued by the U.S. Department of Justice. Amedisys Inc said that the Subpoena requests the delivery of information regarding 53 identified hospice patients to the United States Attorney's Office for the District of Massachusetts and that it also requests the delivery of documents relating to the Company's hospice clinical and business operations and related compliance activities. The Subpoena generally covers the period from January 1, 2011, through the present."
On June 8, 2015, NASDAQ:AMED shares closed at $34.64 per share.
Those who purchased shares of Amedisys Inc (NASDAQ:AMED) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego